REN and Hyperglycemia: Furthermore, the current therapeutic options, including blood pressure optimization, optimal control of hyperglycemia and lipid levels, and maximizing the renin-angiotensin-aldosterone system blockade can only slow but not block the progression of DKD (Nathan et al., 2013).